| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_234c1a9cbf5c8fef3e2f82667384409f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb1e7edd437890f04f805ed9d52e1589
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89be1b620c696d4d1c46f938d402406e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_577821cf81fda3e1088e6ed08bcd136b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-21001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate |
2002-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaaff1be98a8ac7141134acfe05ef287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fedb90cea55efee2415700daacbb25a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1d2e99a902d0889b35f9a50559f990d |
| publicationDate |
2003-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02083167-A3 |
| titleOfInvention |
Therapeutic compositions for the treatment of a respiratory tract disease |
| abstract |
The equilibrium between G actin and F actin is shifted towards the F actin confirmation with compounds such as the ionic form of magnesium or potassium. The higher amount of F actin decreases the inhibition of nucleases such as DNAse I by monomeric G actin. The increased performance of the nuclease results in better treatment of patients suffering from cystic fibrosis or other diseases associated with viscous mucus. |
| priorityDate |
2001-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |